Enhancement of paclitaxel activity against hormone-refractory prostate cancer cells in vitro and in vivo by quinacrine.

Cytoplasmic phospholipase A2 (PLA2) is known to be phosphorylated and activated by MAP kinase (Lin et al 1993, Cell 72: 269-278), an important downstream component of signal transduction, whereas paclitaxel has been shown to inhibit isoprenylation of ras proteins (Danesi et al 1995, Mol Pharmacol 47...

Descripción completa

Detalles Bibliográficos
Autores principales: de Souza, P. L., Castillo, M., Myers, C. E.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223533/
https://www.ncbi.nlm.nih.gov/pubmed/9184173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223533/
https://www.ncbi.nlm.nih.gov/pubmed/9184173

Ejemplares similares